Skip to content
ViraxImmune™
Media
Leadership
Contact
Investor Relations
ViraxImmune™
Media
Leadership
Contact
Investor Relations
COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States
December 6 2022
View Our Press Release